Gene · 683
Papers2,228
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,228
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression Profile of CD157 Reveals Functional Heterogeneity of Capillaries in Human Dermal Skin. | Biomedicines | 2022 | 35327478 | PubTator, text mining | PubMed |
| The Role of CD200-CD200 Receptor in Human Blood and Lymphatic Endothelial Cells in the Regulation of Skin Tissue Inflammation. | Cells | 2022 | 35326506 | PubTator, text mining | PubMed |
| Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function. | Food Chem Toxicol | 2022 | 35307453 | PubTator, text mining | PubMed |
| Mitochondrial transport and metabolism of the vitamin B-derived cofactors thiamine pyrophosphate, coenzyme A, FAD and NAD+ , and related diseases: A review. | IUBMB Life | 2022 | 35304818 | PubTator, text mining | PubMed |
| CD38-NADase is a new major contributor to Duchenne muscular dystrophic phenotype. | EMBO Mol Med | 2022 | 35298089 | PubTator, text mining | PubMed |
| Dihydronicotinamide Riboside Is a Potent NAD+ Precursor Promoting a Pro-Inflammatory Phenotype in Macrophages. | Front Immunol | 2022 | 35281060 | PubTator, text mining | PubMed |
| Predictors of RBD progression and conversion to synucleinopathies. | Curr Neurol Neurosci Rep | 2022 | 35274191 | PubTator, text mining | PubMed |
| COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19. | Int J Mol Sci | 2022 | 35269564 | PubTator, text mining | PubMed |
| CD38 inhibitor 78c increases mice lifespan and healthspan in a model of chronological aging. | Aging Cell | 2022 | 35263032 | PubTator, text mining | PubMed |
| Inflammation and immune dysfunction in Parkinson disease. | Nat Rev Immunol | 2022 | 35246670 | PubTator, text mining | PubMed |
| Therapeutic correction of hemophilia A using 2D endothelial cells and multicellular 3D organoids derived from CRISPR/Cas9-engineered patient iPSCs. | Biomaterials | 2022 | 35217482 | PubTator, text mining | PubMed |
| Oral Supplementation with L-Carnosine Attenuates Social Recognition Deficits in CD157KO Mice via Oxytocin Release. | Nutrients | 2022 | 35215455 | PubTator, text mining | PubMed |
| Screening for Regulatory Network of miRNA-Inflammation, Oxidative Stress and Prognosis-Related mRNA in Acute Myocardial Infarction: An in silico and Validation Study. | Int J Gen Med | 2022 | 35210840 | PubTator, text mining | PubMed |
| A Retrospective Digital Analysis of Contour Changing after Tooth Extraction with or without Using Less Traumatic Surgical Procedures. | J Clin Med | 2022 | 35207192 | PubTator, text mining | PubMed |
| The spectrum of paroxysmal nocturnal hemoglobinuria clinical presentation in a Brazilian single referral center. | Ann Hematol | 2022 | 35182190 | PubTator, text mining | PubMed |
| Life-or-death decisions in plant immunity. | Curr Opin Immunol | 2022 | 35168119 | PubTator, text mining | PubMed |
| Roles of α-Synuclein and Disease-Associated Factors in Drosophila Models of Parkinson's Disease. | Int J Mol Sci | 2022 | 35163450 | PubTator, text mining | PubMed |
| Circulating NAD+ Metabolism-Derived Genes Unveils Prognostic and Peripheral Immune Infiltration in Amyotrophic Lateral Sclerosis. | Front Cell Dev Biol | 2022 | 35155438 | PubTator, text mining | PubMed |
| Roles of the Exosomes Derived From Myeloid-Derived Suppressor Cells in Tumor Immunity and Cancer Progression. | Front Immunol | 2022 | 35154134 | PubTator, text mining | PubMed |
| The CD38 glycohydrolase and the NAD sink: implications for pathological conditions. | Am J Physiol Cell Physiol | 2022 | 35138178 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/683/papers?page=14